Regulation of the Chemokine Receptor CXCR4 by Hypoxia

Author:

Schioppa Tiziana1,Uranchimeg Badarch2,Saccani Alessandra1,Biswas Subhra K.1,Doni Andrea1,Rapisarda Annamaria2,Bernasconi Sergio1,Saccani Simona3,Nebuloni Manuela4,Vago Luca4,Mantovani Alberto15,Melillo Giovanni2,Sica Antonio1

Affiliation:

1. Istituto di Ricerche Farmacologiche “Mario Negri, ” 20157 Milan, Italy

2. Development Therapeutic Program, Tumor Hypoxia Laboratory, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, MD 21702

3. Institute for Research in Biomedicine, Bellinzona, CH6500 Switzerland

4. Institute of Pathology, Department of Clinical Sciences “L. Sacco,” University of Milan, 20157 Milan, Italy

5. Centro di Eccellenza per l'Innovazione Diangnostica e Terapeutica, Institute of Pathology, State University of Milan, 20133 Milan, Italy

Abstract

Cell adaptation to hypoxia (Hyp) requires activation of transcriptional programs that coordinate expression of genes involved in oxygen delivery (via angiogenesis) and metabolic adaptation (via glycolysis). Here, we describe that oxygen availability is a determinant parameter in the setting of chemotactic responsiveness to stromal-derived factor 1 (CXCL12). Low oxygen concentration induces high expression of the CXCL12 receptor, CXC receptor 4 (CXCR4), in different cell types (monocytes, monocyte-derived macrophages, tumor-associated macrophages, endothelial cells, and cancer cells), which is paralleled by increased chemotactic responsiveness to its specific ligand. CXCR4 induction by Hyp is dependent on both activation of the Hyp-inducible factor 1 α and transcript stabilization. In a relay multistep navigation process, the Hyp–Hyp-inducible factor 1 α–CXCR4 pathway may regulate trafficking in and out of hypoxic tissue microenvironments.

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Cited by 715 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3